Jeani Delagardelle is a Managing Director and leads our medical device practice, with almost 30 years of experience in that industry. Jeani joined Sprout in August 2000 and became General Partner in July 2001. She was one of the founders of New Leaf upon its spin-out from Sprout in 2005. 

Previously, she was a General Partner at Weiss, Peck & Greer Venture Partners where she focused on healthcare/technology investments. Before joining Weiss, Peck & Greer Venture Partners, Jeani spent 15 years in senior marketing, sales, business development and general manager positions in the healthcare industry. Specifically, she was Vice President of Global Marketing for Target Therapeutics (acquired by Boston Scientific for $1.1B) and spent nine years with the Medi-tech division of Boston Scientific in several senior management roles. In addition, Jeani served as Director of Business Operations for Roche Laboratories and Director of Global Marketing for Cell Pro, Inc. Jeani attended University of California at Irvine (M.B.A.) and Occidental College (A.B.).

Fund's investment verticals: bio-pharmaceuticals, information convergence, medical devices, and biological research tools and infrastructure.